Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
558,617,192
-
Share change
-
+51,963,970
-
Total reported value
-
$4,501,147,777
-
Put/Call ratio
-
114%
-
Price per share
-
$8.07
-
Number of holders
-
384
-
Value change
-
+$430,391,642
-
Number of buys
-
159
-
Number of sells
-
186
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2022
As of 30 Sep 2022,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
384 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
558,617,192 shares.
The largest 10 holders included
Capital Research Global Investors, BlackRock Inc., Capital World Investors, ABRAMS CAPITAL MANAGEMENT, L.P., MENORA MIVTACHIM HOLDINGS LTD., Migdal Insurance & Financial Holdings Ltd., Phoenix Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, STATE STREET CORP, and Harel Insurance Investments & Financial Services Ltd..
This page lists
389
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.